Shivakumar Sharath Belame, Bharti Dinesh, Jang Si-Jung, Hwang Sun-Chul, Park Ji-Kwon, Shin Jeong-Kyu, Byun June-Ho, Park Bong-Wook, Rho Gyu-Jin
Department of Vet OBS/Theriogenology and Biotechnology, Gyeongsang National University, Jinju, Korea.
Department of Orthopaedic Surgery, School of Medicine, Gyeongsang National University, Jinju, Korea.
Int J Stem Cells. 2015 Nov;8(2):155-69. doi: 10.15283/ijsc.2015.8.2.155.
To compare the effect of three different cryoprotectants on basic stem cell characteristics for the possibility of using well defined, dimethyl sulfoxide (DMSO) and serum free freezing solutions to cryopreserve human Wharton's jelly-derived mesenchymal stem cells (WJMSCs) following controlled rate freezing protocol.
The mesenchymal stem cells isolated from human Wharton's jelly were cryopreserved using 10% DMSO, 10% polyvinylpyrrolidone (PVP) and a cocktail solution comprising of 0.05 M glucose, 0.05 M sucrose and 1.5 M ethylene glycol following controlled rate freezing protocol. We investigated the post-thaw cell viability, morphology, proliferation capacity, basic stem cell characteristics, in vitro differentiation potential and apoptosis-related gene expression profile before and after cryopreservation.
The cryoprotectant 10% DMSO has shown higher post-thaw cell viability of 81.2±0.58% whereas 10% PVP and cocktail solution have shown 62.87±0.35% and 72.2±0.23%, respectively at 0 h immediately thawing. The cell viability was further reduced in all the cryopreserved groups at 24 h later post-thaw culture. Further, the complete elimination of FBS in cryoprotectants has resulted in drastic reduction in cell viability. Cryopreservation did not alter the basic stem cell characteristics, plasticity and multipotency except proliferation rate. The expression of pro-apoptotic BAX and p53 genes were higher whilst p21 was lower in all the cryopreserved groups when compare to the control group of WJMSCs.
Although 10% DMSO has shown higher post-thaw cell viability compare to 10% PVP and cocktail solution, the present study indicates the feasibility of developing a well-defined DMSO free cryosolution which can improve storage and future broad range applications of WJMSCs in regenerative medicine without losing their basic stem cell characteristics.
比较三种不同的冷冻保护剂对基本干细胞特性的影响,探讨使用成分明确的无二甲亚砜(DMSO)血清冷冻溶液,按照程序降温方案冻存人脐带华通氏胶间充质干细胞(WJMSCs)的可能性。
从人脐带华通氏胶中分离出的间充质干细胞,按照程序降温方案,分别使用10% DMSO、10%聚乙烯吡咯烷酮(PVP)以及由0.05 M葡萄糖、0.05 M蔗糖和1.5 M乙二醇组成的混合溶液进行冻存。我们研究了冻存前后解冻后细胞活力、形态、增殖能力、基本干细胞特性、体外分化潜能以及凋亡相关基因表达谱。
在立即解冻0小时时,冷冻保护剂10% DMSO显示出较高的解冻后细胞活力,为81.2±0.58%,而10% PVP和混合溶液分别为62.87±0.35%和72.2±0.23%。在解冻后培养24小时时,所有冻存组的细胞活力进一步降低。此外,冷冻保护剂中完全去除胎牛血清(FBS)导致细胞活力大幅下降。除增殖率外,冻存未改变基本干细胞特性、可塑性和多能性。与WJMSCs对照组相比,所有冻存组中促凋亡基因BAX和p53的表达较高,而p21的表达较低。
尽管10% DMSO与10% PVP和混合溶液相比显示出较高的解冻后细胞活力,但本研究表明开发一种成分明确的无DMSO冷冻溶液是可行的,该溶液可改善WJMSCs在再生医学中的储存及未来广泛应用,且不会丧失其基本干细胞特性。